Home About Us Services ↳ Canada PR Visa (Permanent Residency) ↳ Work Permit Canada ↳ LMIA — Labour Market Impact Assessment ↳ Spouse & Family Sponsorship Visa ↳ Student Visa Canada ↳ Visitor Visa ↳ Business Visa Provinces ↳ 🏙️ Ontario ↳ 🏔️ British Columbia ↳ 🌾 Alberta ↳ 🌻 Saskatchewan ↳ 🌊 Manitoba ↳ ⚓ Nova Scotia ↳ 🍁 New Brunswick ↳ 🦞 Prince Edward Island ↳ 🐟 Newfoundland & Labrador ↳ 🌊 Atlantic Immigration Program Healthcare Blog FAQ Careers Canadian Latest policies Contact

Scientific Advisory Committee on Medical Devices Used in the Cardiovascular System: Summary of affiliations and interests

On this page

Purpose of the Summary of Affiliations and Interests

The following summarizes the information about expertise or experience, affiliations and interests relevant to the Scientific Advisory Committee on Medical Devices Used in the Cardiovascular System (SAC-MDUCS) mandate declared by committee members. Health Canada considered these declarations as part of the selection process. The Health Products and Food Branch has made this summary available as part of its commitment to be transparent about the membership of its advisory bodies.

Assessment of affiliations and interests prior to each meeting

Prior to each committee meeting, Health Canada assesses members' affiliations and interests, including direct financial interests, as they may apply to agenda items for discussion. Depending on the nature of the member's affiliations or interests, the Chair of the committee in consultation with the members, may limit the participation of a member in the meeting or ask him/her to make a verbal statement of affiliations and interests at the beginning of the meeting. Members' affiliations and interests are reviewed on an annual basis and updated as required based on changes in the status of their affiliations and interests.

In accordance with the Health Products and Food Branch Review of Regulated Products: Policy on Public Input and Guidance on Advisory Bodies, a person with a direct financial interest in the outcome of a review of a regulated product may be a member of an advisory body whose broader mandate encompasses matters of policy, management, or program development. However, such a member would not be asked to participate in any discussion, formulation of advice, or recommendations to Health Canada relating to that review.

Indicated [Sector/Perspective] and [Expertise/Experience]

Sector/perspective:

  • Health professional
  • Research
  • Academia

Expertise/experience

  • Interventional radiology
  • Cardiology
  • Cardiovascular surgery
  • Interventional cardiology
  • Clinical perfusion
  • Biomedical engineering
  • Cardiac electrophysiology
  • Neurovascular surgery

1. Direct financial interests

  1. Current employment, investments in companies, partnerships, equity, royalties, joint ventures, trusts, real property, stocks, shares or bonds, with the regulated industry

2. Indirect financial interests

  1. Within the past five years, payment from regulated industry for work done or being done, including past employment, contracts or consulting; or financial support including research support, personal education grants, contributions, fellowships, sponsorships, and honoraria.Footnote 1
  2. Within the past five years, materials, discounted products, gifts, or other benefits, or attendance at meetings where all or part of the travel and accommodation costs were provided by the regulated industry.Footnote 2
  3. Within the last three years, grants or other funding from the regulated industry to any of the organizations where you are currently employed or participate in internal decision making.Footnote 3

3. Intellectual interests

  1. Within the last five years, any formal advice or opinion to industry, a government organization or a non-government organization on a matter of relevance to the SAC-MDUCS.
  2. Within the last five years, any published or publicly stated point of view on issues of relevance to the SAC-MDUCS mandate.
  3. Current professional or volunteer affiliations such as membership of professional societies, lobbying, public interest or advocacy groups, of relevance to the SAC-MDUCS.

4. Other

  1. Any other affiliations and interests or potential circumstances that might give a well-informed member of the public reasonable grounds for concern regarding the integrity and objectivity of your participation.

Affiliations and Interests Summaries

Core Membres
Name and Indicated Sector/Perspective and Expertise Experience Summary of Responses

Eric Cohen, MD, FRCPC
(Chair)

Health Professional/Academia; General and Interventional Cardiology

1a) No

2a) Yes

2b) Yes

2c) Yes

3a) Yes

3b) Yes

3c) Yes

4a) No

Comments:   Consultant for numerous medical technology companies.  Travel and expenses for participation in research meetings reimbursed by medical companies.  Sunnybrook Health Science Centre receives grants from medical device companies to facilitate research. As a member of various committees of the Cardiac Care Network (Ontario) has contributed to reports that have provided recommendations to the Ministry of Health and Long-Term Care in Ontario regarding primary PCI and trans-catheter aortic valve implantation.  Has provided public statements through interviews with various media outlets including newspapers, internet and broadcasting.  Member of Canadian Cardiovascular Society and member and Past President of Canadian Association of Interventional Cardiology.

Christopher Feindel, MD, FRCSC, FACS, MSc

Academia/Research; Cardiac Surgery

1a) No

2a) No

2b) No

2c) No

3a) No

3b) No

3c) No

4a) No

Comments: None.

Marino Labinaz, MD, FRCPC, FACC

Academia; Interventional Cardiology

1a) No

2a) Yes

2b) Yes

2c) Yes

3a) Yes

3b) No

3c) Yes

4a) No

Comments: Has received speaking and proctoring honoraria; University of Ottawa Heart Institute receives donations from regulated industry; Receives travel reimbursement from medical technology companies.  Heart Institute receives research grants from medical technology companies to facilitate research.  Advisory Board member for Medical Devices Advisory Board of Health Canada.  Member of: American College of Cardiology.

Alan Menkis, MD, FRCSC

Health Professional/Academia; Cardiovascular and Thoracic Surgery

1a) No

2a) No

2b) No

2c) No

3a) No

3b) No

3c) No

4a) No

Comments:  None.

Joaquim Miró, MD, FRCPC

Health Professional/Academia; Paediatric-Cardiologist

1a) No

2a) Yes

2b) No

2c) No

3a) No

3b) No

3c) No

4a) No

Comments: Honorarium for proctoring received from a medical technology company.

Raymond Yee, MD, FRCPC

Academia; Cardiology

1a) No

2a) Yes

2b) No

2c) No

3a) No

3b)No

3c) Yes

4a) No

Comments: Consultant / advisor for a medical technology company.  Receives honoraria fees twice a year and has received a research grant from a medical technology company.  Also a member of the Canadian Hearth Rhythm Society and Canadian Cardiovascular Society.

Christopher Cheung, MD, MPH, FRCPC

Health professional/Academia; Cardiac Electrophysiology

1a) No

2a) Yes

2b) Yes

2c) No

3a) No

3b) No

3c) Yes

4a) No

Comments:  Received travel and accommodation reimbursement from medical device companies.  Currently on the board of directors for the Canadian Heart Rhythm Society. Education Council member and Digital Education Committee member for the Heart Rhythm Society.

Shelley Zieroth, MD, FCCS, FHFSA (hon), FESC, FACC, FHFA, FRCPC

Health professional/ Academia; Heart Failure

1a) No

2a) Yes

2b) No

2c) No

3a) Yes

3b) Yes

3c) No

4a) No

Comments: Received research grant support, served on advisory boards for or speaker engagements with, Abbott, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, CSL Vifor, Cytokinetics, Edwards, Eli Lilly, GSK, Medtronic, Merck, Novartis, Novo-Nordisk, and Pfizer and serves on a clinical trial committee for studies sponsored by AstraZeneca, Boehringer Ingelheim, Cytokinetics, Merck, Novartis, Pfizer, Salubris Bio., Canadian Medical and Surgical KT Group, CCS, CHFS, Charite, EOCI, Liv, Medscape, Ology, PACE-CME, Radcliffe, Reach MD, Translational Medicine Academy, Voxmedia.

She is also involved in the EMPOWER Trial run by Carillion.

Has provided formal advice or opinions to Abbott.

Has participated in the Edwards Symposium - Hot or Not Debate - Transcatheter Tricuspid Interventions Now and Tomorrow - Update and current status on transcatheter therapies for tricuspid regurgitation – ESC London UK

Julianne Code, Ph.D

Health Professional/translational research, student agency and learning technology

1a) No

2a) Np

2b) No

2c) No

3a) No

3b) No

3c) Yes

4a) No

Comments: Co-Founder of the HeartLife Foundation of Canada which is a charity for heart failure patients. Many heart failure patients have to have CV devices.

Footnotes

Footnote 1

Other than from present employer.

Return to footnote 1 referrer

Footnote 2

Other than from present employer, over $1,000.

Return to footnote 2 referrer

Footnote 3

"participate in internal decision making" means as a board member, or as an executive or non-executive director.

Return to footnote 3 referrer

Page details

2026-11-13

Quick Enquiry

We usually reply within a few hours
By submitting you agree to be contacted about your enquiry.
Call us☎ Chat on WhatsApp✆
M

Migova AI Assistant

Online now
Hi 👋 I'm the Migova AI assistant, powered by OpenAI. Ask me about PR, study visas, work permits, LMIA, family sponsorship, provinces, or healthcare immigration to Canada.
Canada PR
Study Visa
LMIA / Work Permit